As of Apr 29
| -0.05 / -1.51%|
The 3 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +817.43% increase from the last price of 3.27.
The current consensus among 2 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.